08/11/2018 20:23:17

BioLabs Brings on Veteran Pharma Executive Adam Milne to Lead Operations for its Rapidly Expanding Network of Shared Laboratory Workspaces Designed for Science-Based Startups

CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- BioLabs, a national network of coworking facilities designed to help science-based startups go further faster on limited capital investment, has appointed Adam Milne to the new role of vice president of operations for BioLabs, effective immediately. With this new role, Adam will oversee network standards and processes so that BioLabs can evolve its value proposition systematically for residents, sponsors, and partners as it continues to pursue rapid growth. Mr. Milne will also serve as the managing director for BioLabs’ sites at Tufts LaunchPad BioLabs and Ipsen Innovation Center BioLabs.

According to BioLabs Cofounder and President Johannes Fruehauf, M.D., Ph.D., Milne brings the ideal combination of background and experience to adapt the BioLabs culture for the next phase of company development. “The BioLabs Network has been expanding at a rapid pace across the nation — with high demand for our services around the globe. It takes a special kind of leader who can balance the need for a common structure, processes, and operations across all BioLabs network sites — while maintaining ample flexibility to meet partner needs and the nuances of each local market.”

Adam Milne comes to BioLabs after nearly two decades in the life sciences industry, most recently serving as the Centers for Therapeutic Innovation lead at Pfizer (CTI) — overseeing operations, finance, and academic partnerships for the research unit — and as chief of staff to CTI’s chief scientific officer.  Milne held key operational roles in Pfizer as it was undergoing sweeping changes with mergers and acquisitions, outsourcing research and early development, and partnering with startups to in-and out-license technologies.

“Adam is joining BioLabs during an exciting time,” continued Fruehauf. “He brings a wealth of relevant operational experience, but it is his energy, vision, and focus on team and relationship-building that makes Adam a great fit for the BioLabs leadership team. We could not be more delighted to have him join us. I look forward to working with him so that the pillars that make BioLabs the premier coworking facility for life science entrepreneurs are scalable across the growing national network, yet flexible enough to address site-specific needs.”

Milne has also served on several not-for-profit boards and is currently chairman of Horizons, a national leader in supporting people with developmental disabilities in all aspects of their lives.

“It is with great pleasure that I welcome Adam Milne to the BioLabs team,” added Susie Harborth, cofounder and chief operating officer of BioLabs. “He has the skills and leadership that will help strengthen BioLabs, both at the corporate level as well as at the local sites. He will lead teams that oversee day-to-day operations, while maintaining focus on BioLabs’ mission to enable early-stage, life science entrepreneurs. Adam will be working closely with me and Johannes as we continue to build out our team and expand services for the benefit of our member companies, sponsors, and stakeholders.”

Commenting on his decision to join BioLabs, Milne said, “A major driver for me is the notion that we must strive to create an ecosystem out of which the most compelling and novel therapeutics can arise. BioLabs has indeed created such a place where both innovation and impact thrive. I am honored to be joining a team led by world-class entrepreneurial thinking mixed with an intrinsic desire to shape the face of healthcare as we know it.”

Adam Milne will be based out of the Cambridge and Boston, Massachusetts, locations.

About BioLabs (www.biolabs.io twitter: @biolabsHQ)

A membership-based network of shared laboratory facilities located in key geographies with proven biotech innovation clusters, BioLabs offers beautifully designed coworking environments that pair fully equipped and supported lab, office, and event spaces with relevant programming and unparalleled access to capital and industry partners. These fertile, supportive ecosystems allow young companies to shift their focus from startup operations to experimentation and innovation so they can reach their scientific potential quickly and achieve business success. Companies can start with a single lab bench and scale up as they grow. The expanding BioLabs network now comprises sites in Boston and Cambridge, Massachusetts; Durham, North Carolina; San Carlos, San Diego and San Francisco, California; New York City, and Princeton, New Jersey; and Philadelphia, Pennsylvania; and is developing sites with international partners as well.

Attachment

Caroline Grossman

BioLabs

+1 (781) 771-5579

Caroline@biolabs.io

Veteran pharma exec. Adam Milne joins Cambridge, Mass.-based BioLabs as VP operations. A national network of coworking facilities designed to help science-based startups go further faster on limited capital investment, BioLabs has been expanding rapidly. In order to continue to evolve its value proposition systematically, Milne’s charge is to oversee network standards, assuring common structure, processes, & operations across all network sites, maintaining flexibility to meet partner needs & the nuances of each local market. Since 2010 when BioLabs pioneered its model for shared workspaces for life science startups, it has demonstrated that launching a company in BioLabs’ supportive ecosystem increases the probability of success; BioLabs site startups can focus resources on meeting science & business milestones, with potential of 10-20x less capital investment than building out/operating their own dedicated wet lab/office facilities.

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Aug
VELO
Da flere skribenter stadig gerne vil beholde tråden for samling af de mange vigtige informationer o..
44
19 Aug
OMXC25
Endnu en dansk patriark er død. Ære være hans minde.
28
18 Aug
 
Da Berlingske Media for cirka 1 år siden overtog Euroinvestor for 23 mio kr, meddelte de, at nu skul..
22
20 Aug
VELO
Ny artikel på Medwatch:   15,5 pct. af amerikanske patienter, der får en nyretransplantation i dag, ..
20
18 Aug
VELO
Fra anden skribent i Veloxis FB gruppen: Børsen side 4, søndag den 18. august. Et uddrag fra e..
20
21 Aug
I:NDX
Trump er en forretningsmand, der bevæger sig med en forretningsmands hastighed. Han er fløjtende lig..
18
20 Aug
PNDORA
  har du læst regnskabet - de forventer at tjene 4 mia i 2019 i forhold til en værdi af selskabet på..
18
19 Aug
OMXC25
En fantastisk dygtig og sympatisk erhvervsmand.  Og en ægte patriot som også betalte sin skat med gl..
17
16 Aug
I:NDX
17
20 Aug
GEN
Lige i dette tilfælde er der måake ikke det vilde nye - men det er stadig data på disse konference d..
15

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock
2
MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
3
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
4
Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan
5
Ambu A/S: Interim report for Q3 2018/19

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 August 2019 08:46:56
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB3 - 2019-08-22 09:46:56 - 2019-08-22 08:46:56 - 1000 - Website: OKAY